/PRNewswire/ The Human Insulin Drugs Market in Brazil report has been added to Technavio s offering. The human insulin drugs market in Brazil is estimated.
Gulf Pharmaceutical Industries (Julphar), amid the current political headwinds and currency devaluation in Egypt, posted stable revenue of AED1.25 billion ($340 million) at constant currency in the first nine months (9M) of 2023.
Latin America Insulin Market Set to Soar, Projected to Reach an Impressive US$3,857 5 Million by 2031 | Astute Analytica | medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.
UAE s Julphar Explores Sale of Mideast Chain Planet Pharmacies bloomberg.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bloomberg.com Daily Mail and Mail on Sunday newspapers.